Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2012-09-03 Annual Report
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Annual Report to shareholders 74 pages 1.3MB
Annual Report Classification · 100% confidence The document is titled 'annual report' and contains detailed sections typical of an annual report, including Chairman's Report, Directors' Report, Auditor's Independence Declaration, comprehensive financial statements (Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, Statement of Changes of Equity), Notes to the Financial Statements, Directors' Declaration, Independent Auditor's Report, and Corporate Governance Statement. The content discusses company strategy, partnerships, financial milestones, and industry context, all consistent with a full annual report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2012-09-03 English
Annual General Meeting Date 1 page 21.8KB
AGM Information Classification · 100% confidence The document is a short announcement dated 24 August 2012 from Phylogica Limited regarding the date of their upcoming Annual General Meeting (AGM) scheduled for 15 October 2012. It does not contain any financial data, detailed reports, or results but simply informs shareholders and the market about the AGM date. The document length is only 1421 characters, which is quite short and fits the pattern of an announcement rather than a full report or presentation. Therefore, this document is best classified as AGM Information (AGM-R).
2012-08-23 English
Becoming a substantial holder 2 pages 58.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Notice of Initial Substantial Holder filed under the Corporations Act 2001, Section 671B. It details the substantial shareholding and voting power of an entity in a company, including the number of securities held and the nature of the relevant interest. This type of filing is a notification of a major shareholding change, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about share ownership thresholds being crossed.
2012-08-20 English
Preliminary Final Report 8 pages 38.5KB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary final report Year ended 30 June 2012' for Phylogica Limited. Appendix 4E is a regulatory filing used in Australia for preliminary final reports, which typically accompany or precede the full annual report. The document contains detailed financial statements including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity for the full fiscal year ended 30 June 2012. It also includes notes to the financial statements and audit/review status indicating the accounts have been audited. The length of the document (15,000 characters) and the presence of full financial data and notes confirm this is the actual financial report, not just an announcement or summary. The document corresponds to a full year-end report, which aligns with the definition of an Annual Report (10-K equivalent). Therefore, the correct classification is Annual Report (10-K). FY 2012
2012-08-20 English
Full Year Statutory Accounts 53 pages 983.1KB
Annual Report Classification · 100% confidence The document is titled 'Financial Report 30 June 2012' and includes detailed sections such as Directors' Report, Auditor's Independence Declaration, Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, Statement of Changes in Equity, Notes to the Financial Statements, Directors' Declaration, Independent Auditor's Report, Corporate Governance Statement, and ASX additional information. It covers the full fiscal year ended 30 June 2012 and contains comprehensive financial data and management discussion. The presence of detailed financial statements and audit reports indicates this is a full annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2012
2012-08-20 English
Change of Director's Interest Notice 2 pages 114.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed information about changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the change, and dates. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure related to insider trading or director shareholdings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives. The document length is 3597 characters, which is consistent with a detailed notice rather than a brief announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2012-08-08 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.